Cargando…

Exoproducts of the Most Common Achromobacter Species in Cystic Fibrosis Evoke Similar Inflammatory Responses In Vitro

Achromobacter is a genus of Gram-negative rods, which can cause persistent airway infections in people with cystic fibrosis (CF). The knowledge about virulence and clinical implications of Achromobacter is still limited, and it is not fully established whether Achromobacter infections contribute to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahl, Cecilia, Baumgarten, Maria, Shannon, Oonagh, Påhlman, Lisa I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434066/ https://www.ncbi.nlm.nih.gov/pubmed/37284754 http://dx.doi.org/10.1128/spectrum.00195-23

Ejemplares similares

Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis
por: Khademi, S. M. Hossein, et al.
Publicado: (2021)

Achromobacter spp. genetic adaptation in cystic fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Modulation of translation and induction of autophagy by bacterial exoproducts
por: von Hoven, Gisela, et al.
Publicado: (2012)

Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
por: Chalhoub, Hussein, et al.
Publicado: (2022)

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
por: Lambiase, A., et al.
Publicado: (2011)

Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes
por: Nielsen, Signe M., et al.
Publicado: (2016)

Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance
por: Sandri, Angela, et al.
Publicado: (2022)

VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
por: Neuwirth, Catherine, et al.
Publicado: (2006)

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
por: Firmida, M.C., et al.
Publicado: (2016)

Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
por: Veschetti, Laura, et al.
Publicado: (2020)

Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients
por: Veschetti, Laura, et al.
Publicado: (2021)

Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus
por: Radlinski, Lauren, et al.
Publicado: (2017)

Genetic Adaptation of Achromobacter sp. during Persistence in the Lungs of Cystic Fibrosis Patients
por: Ridderberg, Winnie, et al.
Publicado: (2015)

Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
por: Firmida, Mônica Cássia, et al.
Publicado: (2017)

Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis
por: Tetart, Macha, et al.
Publicado: (2019)

Leishmania infantum Exoproducts Inhibit Human Invariant NKT Cell Expansion and Activation
por: Belo, Renata, et al.
Publicado: (2017)

Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease
por: Stobbelaar, Kim, et al.
Publicado: (2016)

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature
por: Cools, Piet, et al.
Publicado: (2016)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis
por: Le Goff, Mélanie, et al.
Publicado: (2022)

Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304
por: Jeukens, Julie, et al.
Publicado: (2015)

Complete Genome Sequence of Achromobacter xylosoxidans MN001, a Cystic Fibrosis Airway Isolate
por: Badalamenti, Jonathan P., et al.
Publicado: (2015)

Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients
por: Rodrigues, Elenice RA, et al.
Publicado: (2016)

730. Cefiderocol for the Treatment of Achromobacter xylosoxidans Infections in Two Lung Transplant Patients with Cystic Fibrosis
por: Warner, Nathaniel C, et al.
Publicado: (2019)

Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection
por: Sandri, Angela, et al.
Publicado: (2021)

Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
por: Veschetti, Laura, et al.
Publicado: (2021)

Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung
por: Menetrey, Quentin, et al.
Publicado: (2021)

In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics
por: Sandri, Angela, et al.
Publicado: (2023)

High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
por: Menetrey, Quentin, et al.
Publicado: (2020)

In Vitro Activity of 22 Antibiotics against Achromobacter Isolates from People with Cystic Fibrosis. Are There New Therapeutic Options?
por: Beauruelle, Clémence, et al.
Publicado: (2021)

Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis
por: Bali, Vedrana, et al.
Publicado: (2016)

Folding–function relationship of the most common cystic fibrosis–causing CFTR conductance mutants
por: van Willigen, Marcel, et al.
Publicado: (2019)

Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes
por: Jakobsen, Tim Holm, et al.
Publicado: (2013)

The Efficacy of an N-Acetylcysteine–Antibiotic Combination Therapy on Achromobacter xylosoxidans in a Cystic Fibrosis Sputum/Lung Cell Model
por: Aiyer, Aditi, et al.
Publicado: (2022)

Exoproduction and Biochemical Characterization of a Novel Serine Protease from Ornithinibacillus caprae L9(T) with Hide-Dehairing Activity
por: Li, Xiaoguang, et al.
Publicado: (2022)

Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains
por: Trancassini, Maria, et al.
Publicado: (2014)

Pathogenesis of Achromobacter xylosoxidans respiratory infections: colonization and persistence of airway epithelia and differential gene expression in synthetic cystic fibrosis sputum medium
por: Billiot, Caitlin E., et al.
Publicado: (2023)

Polymyxin Resistance and Heteroresistance Are Common in Clinical Isolates of Achromobacter Species and Correlate with Modifications of the Lipid A Moiety of Lipopolysaccharide
por: MacDonald, Lewis, et al.
Publicado: (2022)

Achromobacter Species: An Emerging Cause of Community-Onset Bloodstream Infections
por: Isler, Burcu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ob6iccc3s8hadahmlj0nkeim9